NOVEL THERAPEUTICS FOR FIBROLAMELLAR CARCINOMA

$484,084FY2019Department of the ArmyDOD

Fred Hutchinson Cancer Center, Seattle WA

Investigators

View source on USAspending →

NOVEL THERAPEUTICS FOR FIBROLAMELLAR CARCINOMA · GrantIndex